Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 57,472 shares at $19.26 ($1.1M) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $1.1M CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.08 | 21,236 | $405K | 36.9% |
| 2 | $19.08 | 21,236 | $405K | 36.9% |
| 3 | $19.26 | 5,000 | $96K | 8.8% |
| 4 | $19.26 | 5,000 | $96K | 8.8% |
| 5 | $19.27 | 5,000 | $96K | 8.8% |
| Total | $19.13 avg | 57,472 |
| $1.1M |
| 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |